Lu Lucy 4
4 · AVENUE THERAPEUTICS, INC. · Filed Feb 13, 2020
Insider Transaction Report
Form 4
Lu Lucy
DirectorPresident, CEO
Transactions
- Award
Restricted Stock Units
2020-02-12+110,959→ 246,576 totalExercise: $0.00Exp: 2025-02-12→ Common Stock (110,959 underlying)
Footnotes (1)
- [F1]Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen.